Dunowska Magdalena, Morley Paul S, Traub-Dargatz Josie L, Hyatt Doreene R, Dargatz David A
Animal Population Health Institute, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
J Am Vet Med Assoc. 2006 Jun 15;228(12):1909-17. doi: 10.2460/javma.228.12.1909.
Objective-To evaluate antimicrobial susceptibility of commensal Escherichia coli strains isolated from the feces of horses and investigate relationships with hospitalization and antimicrobial drug (AMD) administration. Design-Observational study. Animals-68 hospitalized horses that had been treated with AMDs for at least 3 days (HOSP-AMD group), 63 hospitalized horses that had not received AMDs for at least 4 days (HOSP-NOAMD group), and 85 healthy horses that had not been hospitalized or treated with AMDs (community group). Procedures-Fecal samples were submitted for bacterial culture, and up to 3 E coli colonies were recovered from each sample. Antimicrobial susceptibility of 724 isolates was evaluated. Prevalence of resistance was compared among groups by use of log-linear modeling. Results-For 12 of the 15 AMDs evaluated, prevalence of antimicrobial resistance differed significantly among groups, with prevalence being highest among isolates from the HOSP-AMD group and lowest among isolates from the community group. Isolates recovered from the HOSP-AMD and HOSP-NOAMD groups were also significantly more likely to be resistant to multiple AMDs. Resistance to sulfamethoxazole and resistance to trimethoprim-sulfamethoxazole were most common, followed by resistance to gentamicin and resistance to tetracycline. Use of a potentiated sulfonamide, aminoglycosides, cephalosporins, or metronidazole was positively associated with resistance to 1 or more AMDs, but use of penicillins was not associated with increased risk of resistance to AMDs. Conclusion and Clinical Relevance-Results suggest that both hospitalization and AMD administration were associated with prevalence of antimicrobial resistance among E coli strains isolated from the feces of horses.
目的——评估从马粪便中分离出的共生大肠杆菌菌株的抗菌药敏性,并研究其与住院治疗及抗菌药物(AMD)使用之间的关系。设计——观察性研究。动物——68匹接受AMD治疗至少3天的住院马(HOSP - AMD组)、63匹至少4天未接受AMD治疗的住院马(HOSP - NOAMD组)以及85匹未住院且未接受AMD治疗的健康马(社区组)。程序——提交粪便样本进行细菌培养,每个样本最多分离出3个大肠杆菌菌落。评估了724株分离菌的抗菌药敏性。采用对数线性模型比较各组间的耐药率。结果——在评估的15种AMD中,有12种的抗菌耐药率在各组间存在显著差异,HOSP - AMD组分离菌的耐药率最高,社区组分离菌的耐药率最低。从HOSP - AMD组和HOSP - NOAMD组分离出的菌株对多种AMD耐药的可能性也显著更高。对磺胺甲恶唑和甲氧苄啶 - 磺胺甲恶唑的耐药最为常见,其次是对庆大霉素和四环素的耐药。使用增效磺胺类药物、氨基糖苷类、头孢菌素类或甲硝唑与对1种或更多AMD耐药呈正相关,但使用青霉素与AMD耐药风险增加无关。结论及临床意义——结果表明,住院治疗和AMD使用均与从马粪便中分离出的大肠杆菌菌株的抗菌耐药率有关。